MRNS

Marinus Pharmaceuticals Inc.

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

MRNS price

Marinus Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MRNS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals MRNS

Valuation

P/E

0.00

Sector 10.41

Industry 11.22

P/BV

0.00

Sector 1.68

Industry 2.44

P/Revenue (PSR)

Sector 0.83

Industry 1.19

EV/EBITDA

0.02

Sector 14.40

Industry 20.25

EV/EBIT

0.02

Sector 19.48

Industry 34.43

P/EBITDA

Sector -6.16

Industry -4.70

P/EBIT

Sector -5.30

Industry -2.11

P/Total Assets

Sector 0.68

Industry 1.07

P/Net Current Assets

0.00

Sector -4.12

Industry -3.03

P/Working Capital

0.00

Sector -5.16

Industry 2.48

EPS

-2.46

Sector 0.98

Industry 0.75

BVPS

-1.17

Sector 10.48

Industry 8.78

Efficiency

Gross Margin

90.15%

Sector 45.44%

Industry 48.11%

EBITDA Margin

-237.12%

Sector 9.56%

Industry 6.80%

EBIT Margin

-238.64%

Sector 5.16%

Industry 4.19%

Operating Margin

-100.00%

Sector 5.33%

Industry 5.98%

Net Profit Margins

-100.00%

Sector 2.23%

Industry 2.80%

Asset Turnover

0.13

Sector 0.22

Industry 0.20

Profitability

ROE

210.52%

Sector 4.19%

Industry 6.50%

ROA

-220.84%

Sector 1.00%

Industry 0.37%

ROIC

-443.43%

Sector -20.41%

Industry -28.52%

Dividends

Dividend yield

0.00%

Sector 0.31%

Industry 0.19%

Payout

Sector 10.24%

Industry 6.90%

Debt

Current Ratio

1.66

Sector 1.05

Industry 1.59

Net Debt / EBITDA

0.02

Sector 0.18

Industry 2.69

Net Debt / EBIT

0.02

Sector 0.67

Industry 3.47

Net Debt / Equity

0.01

Sector -0.17

Industry -0.01

Gross Debt / Equity

-0.62

Sector 0.15

Industry 0.23

Equity/Assets

-1.05

Sector 0.31

Industry 0.40

Liabilities/Assets

2.05

Sector 0.63

Industry 0.57

Growth

5Y Revenue CAGR

43.17%

Sector -

Industry -

5Y Earnings CAGR

7.30%

Sector -

Industry -

Fundamentals MRNS

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
MRNS Marinus Pharmaceuticals Inc.	$0.00	-	0.00%	0.00	0.00	210.52%	-100.00%
V Visa Inc.	$365.00	8.63%	0.72%	27.40	17.60	64.22%	50.78%
PAYX Paychex Inc.	$103.00	-16.88%	3.92%	23.51	11.08	47.12%	27.03%
BKNG Booking Holdings Inc.	$155.91	-28.47%	0.96%	17.93	-11.99	-66.86%	25.53%
MCO Moody's Corporation	$465.12	-1.60%	0.86%	29.07	25.68	88.34%	34.28%
WM Waste Management Inc.	$207.77	-3.26%	1.68%	29.71	8.54	28.75%	11.12%
ROL Rollins Inc.	$30.34	-44.44%	2.22%	29.79	11.08	37.19%	13.55%
CPRT Copart Inc.	$28.18	-37.77%	0.00%	17.74	3.13	17.66%	33.41%
RHI Robert Half International Inc.	$35.91	15.43%	6.40%	32.09	3.05	9.50%	2.17%
CXW CoreCivic Inc.	$34.49	62.46%	0.00%	27.52	2.45	8.89%	5.15%
GMAB Genmab A/S	$34.63	20.54%	0.00%	2.52	0.36	14.34%	16.99%
WMG Warner Music Group Corp.	$27.00	-17.43%	2.78%	21.80	15.21	69.78%	9.10%
FLT Fleetcor Technologies Inc.	$0.00	-	0.00%	19.65	5.88	29.91%	26.13%
EFX Equifax Inc.	$149.51	-41.29%	1.36%	27.36	4.33	15.83%	10.80%
TTEK Tetra Tech Inc.	$34.09	0.24%	0.76%	21.19	4.99	23.56%	8.61%
EXLS ExlService Holdings Inc.	$34.95	-19.02%	0.00%	21.36	6.17	28.86%	11.17%
PKOH Park-Ohio Holdings Corp.	$47.25	139.53%	1.11%	25.83	1.59	6.17%	1.46%
ABM ABM Industries Incorporated	$49.52	12.88%	2.32%	17.36	1.61	9.29%	1.82%
III Information Services Group Inc.	$5.29	-2.31%	3.51%	21.70	2.65	12.19%	4.67%
VSEC VSE Corporation	$179.44	7.28%	0.23%	72.32	1.85	2.56%	5.53%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MRNS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Marinus Pharmaceuticals

Marinus Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

23 years

Founded: 2003

2014

Time since IPO - 12 years

72

Employees

Marinus Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $-66.74 million.

The company employs approximately 72 people and operates in the Services sector, within the Commercial Services industry.

Over the past 12 months, Marinus Pharmaceuticals Inc. reported $31.47 million in revenue, generating net income of $-140.50 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MRNS.

Market cap

Net worth

$-66.74 million

$-66,740,000.00

Assets

$63.62 million

$63,620,000.00

Total Shares Outstanding

57.00 million

57,000,000

Average Daily Trading Volume

$1.91 million

$1,914,396.34

Sector

Services

Industry

Commercial Services

MRNS

MRNS revenue and profits

Financial Results MRNS

DRAG THE FRAME TO SEE MORE DATA

MRNS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

AMZN - Amazon

$246.28 12,89% (12M)

P/E

20.44

0.00%

ROE

24.52%

P/BV

5.01

WMT - Walmart

$108.48 6,73% (12M)

P/E

38.00

0.91%

ROE

21.53%

P/BV

8.18

COST - Costco Wholesale

$900.63 --4,16% (12M)

P/E

45.02

0.62%

ROE

26.38%

P/BV

11.87

JD - JD.com

$26.78 --20,49% (12M)

P/E

9.86

3.47%

ROE

10.72%

P/BV

1.06

HD - Home Depot

$292.89 --26,50% (12M)

P/E

20.99

3.09%

ROE

85.62%

P/BV

17.97

WBA - Walgreens Boots Alliance

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-83.97%

P/BV

0.00

KR - Kroger

$59.16 --7,02% (12M)

P/E

33.81

2.40%

ROE

18.49%

P/BV

6.25

VZ - Verizon Communications

$47.42 18,96% (12M)

P/E

11.88

5.91%

ROE

15.78%

P/BV

1.87